NEUP (Neuphoria Therapeutics) Price-to-Operating-Cash-Flow : 1.50 (As of May. 28, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Neuphoria Therapeutics Price-to-Operating-Cash-Flow?

As of today (2025-05-28), Neuphoria Therapeutics's share price is $6.74. Neuphoria Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $4.50. Hence, Neuphoria Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is 1.50.

The historical rank and industry rank for Neuphoria Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

NEUP' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.09 Med: 1.12 Max: 1.56
Current: 1.5

During the past 13 years, Neuphoria Therapeutics's highest Price-to-Operating-Cash-Flow Ratio was 1.56. The lowest was 1.09. And the median was 1.12.

NEUP's Price-to-Operating-Cash-Flow is ranked better than
98.37% of 306 companies
in the Biotechnology industry
Industry Median: 24.33 vs NEUP: 1.50

Neuphoria Therapeutics's Cash Flow from Operations per share for the three months ended in Mar. 2025 was $6.66. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was $4.50.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -4.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 6.00% per year.

During the past 13 years, Neuphoria Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 56.90% per year. The lowest was -28.20% per year. And the median was 2.90% per year.

Neuphoria Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Neuphoria Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuphoria Therapeutics Price-to-Operating-Cash-Flow Chart

Neuphoria Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Neuphoria Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	1.28

Competitive Comparison of Neuphoria Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Neuphoria Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neuphoria Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neuphoria Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Neuphoria Therapeutics's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Neuphoria Therapeutics Price-to-Operating-Cash-Flow Calculation

Neuphoria Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	6.74	/	4.497
	=	1.50

Neuphoria Therapeutics's Share Price of today is $6.74.
Neuphoria Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.50.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Neuphoria Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Neuphoria Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuphoria Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuphoria Therapeutics Inc (NAS:NEUP) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Summit Dr, Burlington, MA, USA, 01803

Website

https://www.bionomics.com.au

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.